Order Article Reprints

Kanda T, Nakamura M, Yasui S, Haga Y, Tawada A, Suzuki E, Ooka Y, Takahashi K, Sasaki R, Wu S, et al. Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus Ribavirin. Biology. 2017; 6(2):30. https://doi.org/10.3390/biology6020030

Kanda, Tatsuo, Masato Nakamura, Shin Yasui, Yuki Haga, Akinobu Tawada, Eiichiro Suzuki, Yoshihiko Ooka, Koji Takahashi, Reina Sasaki, Shuang Wu, and et al. 2017. "Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus Ribavirin" Biology 6, no. 2: 30. https://doi.org/10.3390/biology6020030

Kanda, T., Nakamura, M., Yasui, S., Haga, Y., Tawada, A., Suzuki, E., Ooka, Y., Takahashi, K., Sasaki, R., Wu, S., Nakamoto, S., Arai, M., Imazeki, F., & Yokosuka, O. (2017). Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus Ribavirin. Biology, 6(2), 30. https://doi.org/10.3390/biology6020030